Close Menu

NEW YORK – PerkinElmer kicked off the 39th Annual JP Morgan Healthcare Conference by providing an overview of 2020 with some projections for the year ahead and beyond.

Prior to its presentation, the firm announced that Q4 2020 revenues are expected to be about 66 percent above Q4 2019 levels on a reported basis and about 63 percent above the year-ago figure organically.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.